This briefing presents interim findings to inform the debate over extending the Terrorism Risk Insurance Act (TRIA). The results suggest that TRIA performs well on outcomes examined for conventional attacks but not as well for chemical, biological, radiological, or nuclear (CBRN) attacks, but adding a requirement for insurers to offer CBRN coverage is not an ideal solution.
